Optiver Holding
IRMD icon

Optiver Holding’s iRadimed IRMD Stock Holding History

Optiver Holding’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.51K Buy
78
+40
+105% +$4K ﹤0.01% 1298
2025
Q4 		$3.7K Sell
38
-10
-21% -$858 ﹤0.01% 1592
2025
Q3 		$3.42K Buy
+48
New +$3.2K ﹤0.01% 2081

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Optiver Holding's IRMD Position: Q1 2026 in Review

Optiver Holding increased its iRadimed (IRMD) stake by 105% in Q1 2026, buying an estimated $4K and bringing the position to 78 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

Optiver Holding first reported a position in IRMD in Q3 2025 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Optiver Holding held 78 shares of iRadimed worth $7.51K as of Q1 2026.
  • Optiver Holding bought 40 iRadimed shares in Q1 2026, an estimated $4K.
  • iRadimed made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1298 holding.
  • Optiver Holding first reported a position in iRadimed in Q3 2025 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.